Clayton Deighan's Biography

Clayton Deighan, North American Sales and Applications Manager, NanoFCM

Dr. Clayton Deighan completed his PhD in Dr. Jeff Chalmers lab at Ohio State in 2015 and has spent the years since working with EV investigators around the world on characterization of single EVs. He has now joined NanoFCM as the leader of their applications and sales teams in North America and is excited to bring their EV detection technologies to researchers around the world.

Routine Single EV Protein Biomarker Analysis

Thursday, 28 March 2019 at 16:30

Add to Calendar ▼2019-03-28 16:30:002019-03-28 17:30:00Europe/LondonRoutine Single EV Protein Biomarker AnalysisExtracellular Vesicle-based Dx and Rx Summit in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

One of the major limitations to the realization of the potential in EV biomarkers is the lack of techniques for phenotyping individual EVs. In this presentation we will present the ExoView platform, a new tool for the capture and characterization of EVs from many sources. By coupling a validatable immunoassay for capturing EVs with no prior purification with a sensitive interferometric measurement of single EVs (50+nm) with no additional labeling we separate important populations from the noise. The secondary analysis by counterstaining for biomarkers of interest can be custom designed by the user allowing for detection of the markers of interest in their research with minimal assay development time. Example datasets for marker colocalization will be presented for EVs from a variety of sources.

Add to Calendar ▼2019-03-28 00:00:002019-03-28 00:00:00Europe/LondonExtracellular Vesicle-based Dx and Rx SummitExtracellular Vesicle-based Dx and Rx Summit in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors